Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

November 03, 2016 07:05 ET | Source: Immunovaccine Inc.

Neoepitope Peptides Formulated in Immunovaccine's DepoVax(TM) Vaccine Platform Show Significant Positive Results in Preclinical Studies

HALIFAX, NOVA SCOTIA--(Marketwired - Nov. 3, 2016) - Immunovaccine Inc. ("Immunovaccine" or the "Company") (TSX:IMV)(OTCQX:IMMVF), a clinical stage vaccine and immunotherapy company,...
November 01, 2016 07:05 ET | Source: Immunovaccine Inc.

Immunovaccine Appoints Gabriela Rosu, M.D., as Company's First Chief Medical Officer

HALIFAX, NOVA SCOTIA--(Marketwired - Nov. 1, 2016) - Immunovaccine Inc. ("Immunovaccine" or the "company") (TSX:IMV)(OTCQX:IMMVF), a clinical stage vaccine and immunotherapy company,...
October 13, 2016 07:05 ET | Source: Immunovaccine Inc.

Immunovaccine Announces Positive Phase 1 Topline Data for DepoVax(TM)-based Respiratory Syncytial Virus Vaccine Candidate

HALIFAX, NOVA SCOTIA--(Marketwired - Oct. 13, 2016) - Immunovaccine Inc. ("Immunovaccine" or the "Company") (TSX:IMV)(OTCQX:IMMVF), a clinical stage vaccine and immunotherapy company,...
October 11, 2016 07:05 ET | Source: Immunovaccine Inc.

Positive Preclinical Data for Immunovaccine's DepoVax(TM)-based Malarial Vaccine Presented at 2016 World Vaccine Congress Europe

HALIFAX, NOVA SCOTIA--(Marketwired - Oct. 11, 2016) - Immunovaccine Inc. ("Immunovaccine" or the "company") (TSX:IMV)(OTCQX:IMMVF), a clinical stage vaccine and immunotherapy company,...
October 06, 2016 07:05 ET | Source: Immunovaccine Inc.

Immunovaccine to Present at 2016 BIO Investor Forum

HALIFAX, NOVA SCOTIA--(Marketwired - Oct. 6, 2016) - Immunovaccine Inc. (TSX:IMV) (OTCQX:IMMVF), a clinical stage vaccine and immunotherapy company, today announced that it will...
October 03, 2016 07:05 ET | Source: Immunovaccine Inc.

Immunovaccine Announces Transition of Chief Financial Officer Role

HALIFAX, NOVA SCOTIA--(Marketwired - Oct. 3, 2016) - Immunovaccine Inc. ("Immunovaccine" or the "company") (TSX:IMV)(OTCQX:IMMVF), a clinical stage vaccine and immunotherapy company,...
September 23, 2016 07:05 ET | Source: Immunovaccine Inc.

Researchers to Present Data on Immunovaccine's Infectious Disease Pipeline at Three International Conferences

HALIFAX, NOVA SCOTIA--(Marketwired - Sept. 23, 2016) - Immunovaccine Inc. ("Immunovaccine" or the "Company") (TSX:IMV)(OTCQX:IMMVF), a clinical-stage vaccine and immunotherapy company,...
September 20, 2016 07:05 ET | Source: Immunovaccine Inc.

Immunovaccine to Present Pre-Clinical Data at the 2016 CRI-CIMT-EATI-AACR International Cancer Immunotherapy Conference: Translating Science into Survival

HALIFAX, NOVA SCOTIA--(Marketwired - Sept. 20, 2016) - Immunovaccine Inc. ("Immunovaccine" or the "Company") (TSX:IMV)(OTCQX:IMMVF), a clinical-stage vaccine and immunotherapy company,...
September 08, 2016 07:05 ET | Source: Immunovaccine Inc.

Immunovaccine Announces Dosing of First Patient in Phase 1b Clinical Trial for DPX-Survivac in Combination With Incyte's IDO1 Enzyme Inhibitor Epacadostat

HALIFAX, NOVA SCOTIA--(Marketwired - Sept. 8, 2016) - Immunovaccine Inc. ("Immunovaccine" or the "Company") (TSX:IMV)(OTCQX:IMMVF), a clinical stage vaccine and immunotherapy company,...
September 01, 2016 07:05 ET | Source: Immunovaccine Inc.

Immunovaccine to Present at 2016 Rodman & Renshaw Global Investment Conference

HALIFAX, NOVA SCOTIA--(Marketwired - Sept. 1, 2016) - Immunovaccine Inc. (TSX:IMV) (OTCQX:IMMVF), a clinical stage vaccine and immunotherapy company, today announced that it will...